- Global Vitamin D3 markets remained firm early in Q2’26 before softening toward June as cautious purchasing, inventory releases, and weaker spot demand reduced momentum.
- Feedstock and production pressures remained elevated initially as energy, chemical-input, and logistics costs stayed firm, but improving availability gradually reduced cost-driven support.
- Downstream demand remained stable across supplements, pharmaceuticals, and animal nutrition, although earlier contracting reduced fresh procurement and encouraged hand-to-mouth purchasing during late Q2.
Asia
The Asian Vitamin D3 market remained stable, except for initial firmness driven by supply concerns and elevated production costs in the second quarter of 2026. Buyers were cautious, however, because many had already covered a large share of their quarterly requirements. By the mid-quarter, fresh orders slowed and sellers became more willing to move inventory. Trading activity picked up briefly in June ahead of a major pharmaceutical exhibition in Shanghai, but several producers later suspended quotations, which brought some supply caution back into the market.
Europe
The European Vitamin D3 market environment was relatively stable during April and May due to the presence of early contracted positions and fears about global supply. Declining market pressure was noticeable in June as buyers scaled down their spot buying activities, while distributors concentrated on their stock management operations. Pharmaceutical requirements represented the background consumption structure in the market, with vitamin D-based medicines available in Europe in the form of oral drops, capsules, and other forms. Nevertheless, such underlying demand was not enough to compensate for weakening short-term buying activity.
North America
North American Vitamin D3 markets shared the same trend as its counterparts as the prices stayed strong initially but became softer as inventory was released by producers and consumers held back making any further orders. The trade policy did not cause any initial disruption in the market as pharmaceutical products were eligible for exemption from the temporary 10.0% import surcharge imposed on general imports. Feed applications remained important because livestock formulations depend heavily on supplemental Vitamin D3, limiting substitution options during supply disruptions.
Analyst Insight
According to Procurement Resource, Vitamin D3 conditions are expected to remain stable to slightly firm as cautious inventory management balances persistent supplement, pharmaceutical, and feed demand.